The management of musculoskeletal (MSK) disorders is dependent on several factors: geographic location location in the body, cause, patient history, and severity. Treatment options include lifestyle changes, pharmaceutical therapies, and interventional (ie device-based) therapies. Interventional therapies are typically reserved for the most severe cases of bone damage, as well as trauma. Orthobiologics are one such interventional option available to healthcare providers for the treatment of MSK disorders of soft and hard tissues. This analysis covers orthobiologics for the repair and regeneration of bone. Orthobiologics covered include growth factor-based products, bone allograft products, and cellular bone matrices implanted with stem cells. These products represent some of the leading treatment options for repairing damaged bone.

Topics covered by this report include:

·         orthobiologic devices used in the repair and regeneration of bone

·         global market forecasts for 2015 to 2020

·         emerging orthobiologic therapies in development

·         major trends in global healthcare systems

·         key market drivers and limiters

·         estimated revenues and market shares for major competitors in the orthobiologics market

In 2015, the global orthobiologics for the repair and regeneration market was valued at $2,204.8m. Countries/regions covered by the scope of this analysis include the US, Japan, five major EU markets, and the RoW region.